Multiplex Tandem Mass Spectrometry Enzymatic Activity Assay for Newborn Screening of the Mucopolysaccharidoses and Type 2 Neuronal Ceroid Lipofuscinosis
Open Access
- 1 June 2017
- journal article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 63 (6), 1118-1126
- https://doi.org/10.1373/clinchem.2016.269167
Abstract
BACKGROUND: We expanded the use of tandem mass spectrometry combined with liquid chromatography (LC-MS/MS) for multiplex newborn screening of seven lysosomal enzymes in dried blood spots (DBS). The new assays are for enzymes responsible for the mucopolysaccharidoses (MPS-I, -II, -IIIB, -IVA, -VI, and -VII) and type 2 neuronal ceroid lipofuscinosis (LINCL). METHODS: New substrates were prepared and characterized for tripeptidyl peptidase 1 (TPP1), α-N-acetylglucosaminidase (NAGLU), and lysosomal β-glucuronidase (GUSB). These assays were combined with previously developed assays to provide a multiplex LC-MS/MS assay of 7 lysosomal storage diseases. Multiple reaction monitoring of ion dissociations for enzyme products and deuterium-labeled internal standards was used to quantify the enzyme activities. RESULTS: Deidentified DBS samples from 62 nonaffected newborns were analyzed to simultaneously determine (run time 2 min per DBS) the activities of TPP1, NAGLU, and GUSB, along with those for α-iduronidase (IDUA), iduronate-2-sulfatase (I2S), N-acetylgalactosamine-6-sulfatase (GALNS), and N-acetylgalactosamine-4-sulfatase (ARSB). The activities measured in the 7-plex format showed assay response-to-blank-activity ratios (analytical ranges) of 102–909 that clearly separated healthy infants from affected children. CONCLUSIONS: The new multiplex assay provides a robust comprehensive newborn screening assay for the mucopolysaccharidoses. The method has been expanded to include additional lysosomal storage diseases.Keywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK067859)
- National Institutes of Health
This publication has 34 references indexed in Scilit:
- Newborn screening for mucopolysaccharidoses: a pilot study of measurement of glycosaminoglycans by tandem mass spectrometryJournal of Inherited Metabolic Disease, 2016
- Treatment of lysosomal storage disorders: successes and challengesJournal of Inherited Metabolic Disease, 2014
- Improved Reagents for Newborn Screening of Mucopolysaccharidosis Types I, II, and VI by Tandem Mass SpectrometryAnalytical Chemistry, 2014
- Development of a fluorometric microtiter plate based enzyme assay for MPS IVA (Morquio type A) using dried blood spotsMolecular Genetics and Metabolism Reports, 2014
- Oral small molecule therapy for lysosomal storage diseases.2013
- High-Throughput Assay of 9 Lysosomal Enzymes for Newborn ScreeningClinical Chemistry, 2013
- Practical and reliable enzyme test for the detection of Mucopolysaccharidosis IVA (Morquio Syndrome type A) in dried blood samplesClinica Chimica Acta; International Journal of Clinical Chemistry, 2011
- Comparative Triplex Tandem Mass Spectrometry Assays of Lysosomal Enzyme Activities in Dried Blood Spots Using Fast Liquid Chromatography: Application to Newborn Screening of Pompe, Fabry, and Hurler DiseasesAnalytical Chemistry, 2011
- Neuronal ceroid lipofuscinosesBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2009
- Cloning and characterization of the human β-glucuronidase geneGenomics, 1990